ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
100 319,30
-0,35%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Repligen Corp (RGEN)

  7. Repligen Corp (RGEN) Actualités

RGEN

Repligen (RGEN)

Repligen Corp
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RGEN
DateHeureSourceTitreSymboleSociété
07/01/202513h30GlobeNewswire Inc.Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RGENRepligen Corp
06/01/202513h30GlobeNewswire Inc.Repligen Launches the CTech™ SoloVPE® PLUS SystemNASDAQ:RGENRepligen Corp
16/12/202414h11PR Newswire (US)BioLife Solutions Appoints Tony J. Hunt to its Board of DirectorsNASDAQ:RGENRepligen Corp
12/12/202413h30GlobeNewswire Inc.Repligen Announces Publication of the Company’s 2023 Corporate Sustainability ReportNASDAQ:RGENRepligen Corp
09/12/202413h30GlobeNewswire Inc.Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed ColumnsNASDAQ:RGENRepligen Corp
06/12/202402h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
21/11/202421h52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
18/11/202418h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RGENRepligen Corp
18/11/202418h08Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RGENRepligen Corp
18/11/202418h06Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:RGENRepligen Corp
12/11/202422h22Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:RGENRepligen Corp
12/11/202417h44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RGENRepligen Corp
12/11/202413h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
12/11/202413h30GlobeNewswire Inc.Repligen Reports Third Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
05/11/202413h30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming Investor ConferencesNASDAQ:RGENRepligen Corp
31/10/202412h30GlobeNewswire Inc.Repligen to Report Third Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
24/09/202413h30GlobeNewswire Inc.Repligen Opens Training & Innovation Center to Elevate Customer ExperienceNASDAQ:RGENRepligen Corp
23/08/202413h30GlobeNewswire Inc.Repligen Corporation to Present at Wells Fargo Healthcare ConferenceNASDAQ:RGENRepligen Corp
20/08/202401h29Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RGENRepligen Corp
30/07/202413h30GlobeNewswire Inc.Repligen Reports Second Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
29/07/202422h00GlobeNewswire Inc.Repligen Announces Agreement to Acquire Chromatography Innovator TanttiNASDAQ:RGENRepligen Corp
16/07/202413h30GlobeNewswire Inc.Repligen to Report Second Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
13/06/202413h00GlobeNewswire Inc.Repligen Announces CEO Transition PlanNASDAQ:RGENRepligen Corp
22/05/202413h30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming June Investor ConferencesNASDAQ:RGENRepligen Corp
07/05/202413h30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming May Investor ConferencesNASDAQ:RGENRepligen Corp
01/05/202413h30GlobeNewswire Inc.Repligen Reports First Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
17/04/202413h30GlobeNewswire Inc.Repligen to Report First Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
19/03/202412h30GlobeNewswire Inc.Repligen Appoints Maggie A. Pax to Board of DirectorsNASDAQ:RGENRepligen Corp
22/02/202422h26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RGENRepligen Corp
21/02/202413h30GlobeNewswire Inc.Repligen Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RGENRepligen Corp
 Showing the most relevant articles for your search:NASDAQ:RGEN

Dernières Valeurs Consultées

LSE
AEO
Aeorema Communications
BIT
Q00568
Leonteq Securities
BIT
UC78P5
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces